World's Best Scientists 2026 revealed!
Jan A.M. Smeitink

Jan A.M. Smeitink

D-Index & Metrics

Genetics

D-Index
111
Citations
40778
World Ranking
520
National Ranking
21

Medicine

D-Index
113
Citations
42711
World Ranking
4999
National Ranking
191

Jan A.M. Smeitink publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Jan A.M. Smeitink sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 457 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Jan A.M. Smeitink D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Jan A.M. Smeitink sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 111 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Research.com Recognitions

  • 2013 - Member of Academia Europaea

Overview

Jan A.M. Smeitink is affiliated with Radboud University in the Netherlands. Their work predominantly spans the fields of Biochemistry, Genetics and Molecular Biology, alongside Medicine. Within these broad areas, their research focuses on specific subfields including Molecular Biology, Clinical Biochemistry, Genetics, Pharmacology, and Physiology.

The scientist's research topics center on several key areas: Mitochondrial Function and Pathology, Metabolism and Genetic Disorders, ATP Synthase and ATPases Research, Genetics and Neurodevelopmental Disorders, Autophagy in Disease and Therapy, Parkinson's Disease Mechanisms and Treatments, and Histone Deacetylase Inhibitors Research.

Jan A.M. Smeitink has contributed to multiple recent publications, including:

  • NDUFS4 deletion triggers loss of NDUFA12 in Ndufs4 mice and Leigh syndrome patients: A stabilizing role for NDUFAF2, 2020, Biochimica et Biophysica Acta (BBA) - Bioenergetics
  • Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction, 2020, Clinical Genetics
  • Hypothesis: mPGES-1-Derived Prostaglandin E2, a So Far Missing Link in COVID-19 Pathophysiology?, 2020, Preprints.org
  • Oxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons, 2020, Scientific Reports
  • Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons, 2021, Stem Cell Reports

The frequent co-authors collaborating with Jan A.M. Smeitink include Richard J. Rodenburg, G. Herma Renkema, Mirian C. H. Janssen, Julien Beyrath, and Frans G. M. Rüssel.

Their research has been disseminated through various publication venues, with notable appearances in:

  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  • Orphanet Journal of Rare Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • BMC Neurology

Jan A.M. Smeitink was recognized as a Member of Academia Europaea in 2013.

Best Publications

  • A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

    Nathalie M.J. van der Put;Fons Gabreëls;Erik M.B. Stevens;Jan A.M. Smeitink

  • Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

    Kees Brinkman;Jan A Smeitink;Johannes A Romijn;Peter Reiss

  • Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway.

    K. Brinkman;H.J.M. ter Hofstede;D.M. Burger;J.A.M. Smeitink

  • The genetics and pathology of oxidative phosphorylation.

    Jan Smeitink;Lambert van den Heuvel;Salvatore DiMauro

  • Mitochondrial ATP synthase: architecture, function and pathology

    An I. Jonckheere;Jan A. M. Smeitink;Richard J. T. Rodenburg

  • The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the Literature

    Hannerieke M. P. van den Hout;Wim Hop;Otto P. van Diggelen;Jan A. M. Smeitink

  • Monogenic Mitochondrial Disorders

    Werner J H Koopman;Peter H G M Willems;Jan A M Smeitink

  • Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation

    Gert C Scheper;Thom van der Klok;Rob J van Andel;Carola G M van Berkel

  • Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism

    Markus Wyss;Jan Smeitink;Ron A. Wevers;Theo Wallimann

  • Mammalian Mitochondrial Complex I: Biogenesis, Regulation, and Reactive Oxygen Species Generation

    Werner J.H. Koopman;Leo G.J. Nijtmans;Cindy E.J. Dieteren;Peggy Roestenberg

  • FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.

    Anu Suomalainen;Anu Suomalainen;Jenni M Elo;Kirsi H Pietiläinen;Anna H Hakonen

  • A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases

    Kornelia Neveling;Ilse Feenstra;Christian Gilissen;Lies H. Hoefsloot

  • Mitochondrial function and morphology are impaired in parkin mutant fibroblasts

    Heather Mortiboys;Kelly Jean Thomas;Werner J. H. Koopman;Stefanie Klaffke

  • Spectrophotometric Assay for Complex I of the Respiratory Chain in Tissue Samples and Cultured Fibroblasts

    Antoon J.M. Janssen;Frans J.M. Trijbels;Rob C.A. Sengers;Jan A.M. Smeitink

  • Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease

    Felix Distelmaier;Felix Distelmaier;Werner J.H. Koopman;Lambertus P. van den Heuvel;Richard J. Rodenburg

  • Isolated complex I deficiency in children: clinical, biochemical and genetic aspects.

    J.L.C.M. Loeffen;J.A.M. Smeitink;J.M.F. Trijbels;A.J.M. Janssen

  • The First Nuclear-Encoded Complex I Mutation in a Patient with Leigh Syndrome

    Jan Loeffen;Jan Smeitink;Ralf Triepels;Roel Smeets

  • Application of a ketogenic diet in children with autistic behavior: pilot study.

    Athanasios Evangeliou;Ioannis Vlachonikolis;Helen Mihailidou;Martha Spilioti

  • Mitochondrial complex I: structure, function and pathology.

    Rolf J. R. J. Janssen;Leo G. Nijtmans;Lambert P. van den Heuvel;Jan A. M. Smeitink

  • Mitochondrial toxicity induced by nucleoside-analogue reserve-transcriptase inhibitors is a key in the pathogenesis of antiretroviral therapy-related lipodystrophy.

    K. Brinkman;J.A.M. Smeitink;J.A. Romijn;P. Reiss

Frequent Co-Authors

Richard J. Rodenburg
Richard J. Rodenburg Radboud University
Peter H. G. M. Willems
Peter H. G. M. Willems Radboud University
Lambert P. van den Heuvel
Lambert P. van den Heuvel Radboud University
Werner J.H. Koopman
Werner J.H. Koopman Radboud University
Leo G. Nijtmans
Leo G. Nijtmans Radboud University
Ron A. Wevers
Ron A. Wevers Radboud University
Eva Morava
Eva Morava Mayo Clinic
Frans J.M. Trijbels
Frans J.M. Trijbels Radboud University
Martijn A. Huynen
Martijn A. Huynen Radboud University Medical Center
Ertan Mayatepek
Ertan Mayatepek Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics in the USA opens doors to a variety of complementary career options and degree pathways in healthcare and life sciences. For those seeking entry-level healthcare positions, pursuing a certification can be both affordable and rewarding. Exploring the medical billing and coding certification cost can help you understand the investment needed for this in-demand field, which requires a sharp eye for detail and is often accessible entirely online.

If your interests lean towards direct patient care, there are also easy to get into nursing programs that provide a practical and achievable route to a stable healthcare career. These programs can be a stepping stone to higher qualifications or specialties.

For those interested in leadership, an accelerated healthcare administration degree could fast-track your journey towards managing health services and systems. With flexible formats, these degrees suit working adults and career changers.

Additionally, a bachelors in health administration is a solid foundation for long-term advancement, combining health and business principles. Whether you choose a scientific or administrative path, an online education can help you achieve your career ambitions efficiently and affordably.

Best Scientists Citing Jan A.M. Smeitink

Trending Scientists

Recently Published Articles